Translucent collagen formulations with a cytotoxic drug
US5750146A · kind A · utility
9Cited by
16References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 1995 |
| Grant date | May 12, 1998 |
| Priority date | — |
| Expiry date | Apr 28, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are translucent proteinaceous compositions comprising collagen and an effective amount of a compatible cytotoxic drug which compositions are characterized by having a single collagen transition temperature of less than about 45.degree. C. Such compositions possess enhanced retention of the cytotoxic drug at the site of injection and are optically translucent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.